Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06862440 · ClinicalTrials.gov registry record
Kegg Fertility Study
A clinical trial of Fertility, sponsored by Lady Technologies.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT06862440: Recruiting study of Fertility, sponsored by Lady Technologies.
NCT06862440 is a study of Fertility that is actively recruiting participants, run by Lady Technologies. The registered enrollment target is 500 participants, above the 182-participant average among 4 other Fertility trials with a reported enrollment target (175% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06862440, a study of Fertility, is actively recruiting participants, sponsored by Lady Technologies.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Fertility Awareness Based Methods (FABMs), such as calendar tracking, basal body temperature (BBT), and monitoring cervical mucus, are widely used but may have limitations in accurately detecting the complete fertility window. Serum hormone measurements and transvaginal ultrasound are more accurate at determining time of ovulation and fertile window, but are costly and inconvenient. Urine-based luteinizing hormone (LH) tests offer improvement. However, LH surge typically occurs 24 to 36 hours prior to ovulation, only capturing the later portion of the fertile window. A novel approach involves using electrical impedance to track compositional changes in cervical mucus, providing real-time, at-home data. The Kegg device (Lady Technologies Inc, San Francisco, CA, USA) is an intravaginal device that measures cervical mucus impedance to monitor fertility status. Previous studies show it has higher sensitivity, specificity, and accuracy compared to BBT alone in determining the ovulation window. This method offers a cost-effective and practical alternative for at-home fertility tracking. The objectives of this study are to: 1. evaluate the association between Kegg electrical impedance readings and cervical mucus observations with regard to determining fertility status; and 2. compare the accuracy of Kegg electrical impedance readings with hormone urine strips in identifying the complete fertile window determined by cervical mucus observations.
Primary Outcome
Electrical impedance measured daily on non-bleeding days for 3 menstrual cycles.
Conditions Studied
Interventions
- DEVICE Kegg
Study Locations (1)
California
- Lady Technologies Inc - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-01-09 |
| Est. Completion | 2027-07-09 |
What NCT06862440 shows while recruiting
NCT06862440 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 182-participant average among 4 other Fertility trials with a reported enrollment target (175% higher).
The record links to 1 condition, with Fertility appearing as the primary indexed condition, and to 1 intervention - of which Kegg is the first listed.
NCT06862440 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06862440 about?
NCT06862440 is a clinical study titled "Kegg Fertility Study". Fertility Awareness Based Methods (FABMs), such as calendar tracking, basal body temperature (BBT), and monitoring cervical mucus, are widely used but may have limitations in accurately detecting the complete fertility window. Serum hormone measurements and transvaginal ultrasound are more accurate ...
What is the current status of trial NCT06862440?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2025-01-09. Estimated completion is 2027-07-09.
What conditions does trial NCT06862440 study?
This clinical trial studies the following conditions: Fertility.
What interventions are being tested in trial NCT06862440?
The interventions under investigation include: Kegg (DEVICE).
Who is sponsoring clinical trial NCT06862440?
This trial is sponsored by Lady Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06862440 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Find Your PATHS (Pragmatic Assessment of a Tool to Help Survivors) to Sexual Health and Parenthood Study
COMPLETED · NA
-
Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women
COMPLETED · NA
-
Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
COMPLETED
-
Validation Study Using a Time-lapse Morphometry MIRI Imaging Incubator
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI